Citations

Showing 10 of 108104 citations.

Temporal lobe contusions on computed tomography are associated with impaired 6-month functional recovery after mild traumatic brain injury: a TRACK-TBI study
Yue, John K. , Winkler, Ethan A. , Puffer, Ross C. , Deng, Hansen , Wagle, Sagar, Morrissey, Molly Rose, Rivera, Ernesto J. , Runyon, Sarah J., Vassar, Mary J. , Taylor, Sabrina R. , Cnossen, Maryse C. , Lingsma, Hester F. , Yuh, Esther L. , Schnyer, David M. , Puccio, Ava M. , Valadka, Alex B. , Okonkwo, David O. , Manley, Geoffrey T. , Investigators, the TRACK-TBI, Schnyer, David M , Phelps, Ryan , Mukherjee, Pratik

Mayo Clinic

Neurological Research | September 3, 2018 | Volume: 40 | Issue: 11 | Pages: 972-981

10.1080/01616412.2018.1505416 | PMID 30175944 Get It

A framework for quality measurement in the presurgical care of chronic rhinosinusitis: a review from the Quality Improvement Committee of the American Rhinologic Society
Mattos, José L. , Rudmik, Luke , Manes, Peter R., Lee, Jivianne, Schneider, John S. , Setzen, Michael, Parasher, Arjun K. , Smith, Timothy L. , Stokken, Janalee K., Stokken, Janalee K. , Smith, Timothy L , Carlson, Matthew L , Mattos, Jose , Soler, Zachary M. , Higgins, Thomas S , Lee, Jivianne T.

Mayo Clinic

International Forum of Allergy & Rhinology | September 3, 2018 | Volume: 8 | Issue: 12 | Pages: 1380-1388

10.1002/alr.22154 | PMID 30175899 Get It

BackgroundQuality improvement (QI) in the management of chronic rhinosinusitis (CRS) is garnering increasing attention. Defining frameworks and metrics to assess the quality of key components in CRS management could assist in reducing unwarranted practice variation and increase high‐quality care.MethodsA panel of the American Rhinologic Society (ARS) QI committee reviewed the literature to determine important presurgical components of CRS care that warrant QI. The evidence was organized into 4 categories: (1) diagnosis, (2) medical management, (3) appropriate patient selection for surgery, and (4) patient‐centered discussion. The combination of these categories was used to develop a framework termed the CRS Appropriate Presurgical Algorithm (CAPA).ResultsPrior to offering surgery for CRS, the best available evidence support the following quality metrics: (1) a guideline‐based diagnosis should be confirmed; (2) appropriate medical management, including a minimum of topical corticosteroid therapy and saline irrigations, should have been attempted (assuming patient tolerance); (3) a computed tomography (CT) scan should be obtained (to confirm the presence of sinus inflammation and for surgical planning); and (4) a patient‐centered discussion regarding treatment options for refractory CRS (ie, alternative medical therapies vs surgery vs observation) while focusing on risks and benefits, the need for long‐term medical compliance, and understanding of patient preferences and expectations.ConclusionDefining metrics that assess key components to CRS care prior to offering surgery has the potential to further improve upon an already successful treatment paradigm, reduce unwarranted practice variation, and to ensure that patients are receiving a similar level of high‐quality care.
Sleep Duration and Excessive Daytime Sleepiness Are Associated with Obesity Independent of Diet and Physical Activity
Maugeri, Andrea , Medina‐Inojosa, José R. , Kunzová, Šárka , Agodi, Antonella , Barchitta, Martina , Sochor, Ondřej , Geda, Yonas E. , Vinciguerra, Manlio , Vinciguerra, Manlio , Medina-Inojosa, José R , Geda, Yonas E , Kunzova, Sarka , López-Jiménez, Francisco

Mayo Clinic

Nutrients | September 3, 2018 | Volume: 10 | Issue: 9 | Pages: 1219

10.3390/nu10091219 | PMID 30177634 Get It

In the European Union, Czech Republic ranks 3rd and 6th for the incidence of obesity and cardiovascular diseases, respectively. Worldwide, short sleep duration and excessive daytime sleepiness (EDS) characterize obese subjects, which in turn exhibit scarce physical activity and unhealthy diet. We aimed to understand the relationship between irregular sleep patterns, obesity and lifestyle factors, such as diet and physical activity, in a vulnerable Czech population. 1482 members of the Kardiovize cohort, a random sample of the Czech urban population, were included in a cross-sectional study. Exposure variables included self-reported sleep duration and EDS, assessed by the Epworth Sleepiness Scale. Primary outcomes were BMI and waist-to-hip ratio or prevalence of obesity and central obesity. Covariates included physical activity and diet. Associations and interactions between variables were evaluated using logistic regression analyses. After adjustment for covariates, short sleep duration (<7 h) was associated with greater odds of overweight (BMI > 25; OR = 1.42; 95%CI = 1.06–1.90; p = 0.020) and obesity (BMI > 30; OR = 1.40; 95%CI = 1.02–1.94; p = 0.047), while EDS was associated with greater odds of central obesity (OR = 1.72; 95%CI = 1.06–2.79; p = 0.030), independent of diet and physical activity. However, due to the cross-sectional nature of our study, further prospective, large-scale studies are needed to evaluate the etiological link and causality between sleep disturbances and obesity.
HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell
Valentín-Guillama, Gabriel, López, Sheila, Kucheryavykh, Yuriy , Chorna, Nataliya , Perez, José R., Ortiz-Rivera, Jescelica , Inyushin, Mikhail , Makarov, Vladimir I. , Valentín-Acevedo, Anibal , Quiñones‐Hinojosa, Alfredo , Boukli, Nawal M. , Kucheryavykh, Lilia , Inyushin, Michael , Acevedo, Sheila N. López , Pérez, Jose

Mayo Clinic

Cancers | September 3, 2018 | Volume: 10 | Issue: 9 | Pages: 301

10.3390/cancers10090301 | PMID 30200472 Get It

Patients infected with human immunodeficiency virus (HIV) are more prone to developing cancers, including glioblastomas (GBMs). The median survival for HIV positive GBM patients is significantly shorter than for those who are uninfected, despite the fact that they receive the same treatments. The nature of the GBM–HIV association remains poorly understood. In this study, we analyzed the effect of the HIV envelope glycoprotein gp120 on GBM cell proliferation. Specifically, we performed cell cycle, western blot, protein synthesis and metabolomics analysis as well as ATP production and oxygen consumption assays to evaluate proliferation and metabolic pathways in primary human glioma cell line, U87, A172 cells and in the HIVgp120tg/GL261 mouse model. Glioma cells treated with gp120 (100 ng/mL for 7–10 days) showed higher proliferation rates and upregulation in the expression of enolase 2, hexokinase and glyceraldehyde-3-phosphate dehydrogenase when compared to untreated cells. Furthermore, we detected an increase in the activity of pyruvate kinase and a higher glycolytic index in gp120 treated cells. Gp120 treated GBM cells also showed heightened lipid and protein synthesis. Overall, we demonstrate that in glioma cells, the HIV envelope glycoprotein promotes proliferation and activation of glycolysis resulting in increased protein and lipid synthesis.
Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis
Ford, Alexander C. , Lacy, Brian E. , Harris, Lucinda A. , Ford, Alexander C , Quigley, Eamonn M.M. , Moayyedi, Paul

Mayo Clinic

American Journal of Gastroenterology | September 3, 2018 | Volume: 114 | Issue: 1 | Pages: 21-39

10.1038/s41395-018-0222-5 | PMID 30177784 Get It

OBJECTIVES: Irritable bowel syndrome (IBS) is a chronic functional bowel disorder that is thought to be due to a disorder of brain–gut function. Drugs acting centrally, such as antidepressants, and psychological therapies may, therefore, be effective. METHODS: We updated a previous systematic review and meta-analysis of randomized controlled trials (RCTs). MEDLINE, EMBASE, PsychINFO, and the Cochrane Controlled Trials Register were searched (up to July 2017). Trials recruiting adults with IBS, which compared antidepressants versus placebo, or psychological therapies versus control therapy or “usual management” were eligible. Dichotomous symptom data were pooled to obtain a relative risk (RR) of remaining symptomatic after therapy, with a 95% confidence interval (CI). RESULTS: The search strategy identified 5316 citations. Fifty-three RCTs, reported in 51 separate articles, were eligible for inclusion: 17 compared antidepressants with placebo, 35 compared psychological therapies with control therapy or “usual management”, and one compared both psychological therapy and antidepressants with placebo. Four of the trials of psychological therapies, and one of the RCTs of antidepressants, were identified since our previous meta-analysis. The RR of IBS symptoms not improving with antidepressants versus placebo was 0.66 (95% CI 0.57–0.76), with similar treatment effects for both tricyclic antidepressants and SSRIs, although with heterogeneity between RCTs of the latter ( I 2 = 49%, P = 0.07). The RR of symptoms not improving with psychological therapies was 0.69 (95% CI 0.62–0.76). Cognitive behavioral therapy, relaxation therapy, multi-component psychological therapy, hypnotherapy, and dynamic psychotherapy were all beneficial when data from two or more RCTs were pooled. There was significant heterogeneity between studies ( I 2 = 69%, P < 0.001) and significant funnel plot asymmetry. There were also issues regarding trial design, including lack of blinding. CONCLUSIONS: Antidepressants are efficacious in reducing symptoms in IBS patients. Psychological therapies also appear to be effective treatments for IBS, although there are limitations in the quality of the evidence, and treatment effects may be overestimated as a result.
Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
Sabbag, Avi , Siontis, Konstantinos C. , Noseworthy, Peter A. , Yao, Xiaoxi , Noseworthy, Peter A , Sabbag, Avi

Mayo Clinic

Korean Circulation Journal | September 3, 2018 | Volume: 48 | Issue: 10 | Pages: 873

10.4070/kcj.2018.0261 | PMID 30238705 Get It

Age-dependent effects of thoracic and capillary blood volume distribution on pulmonary artery pressure and lung diffusing capacity
Coffman, Kirsten E. , Boeker, Matthew G., Carlson, Alex R. , Johnson, Bruce D.

Mayo Clinic

Physiological Reports | September 2, 2018 | Volume: 6 | Issue: 17 | Pages: e13834

10.14814/phy2.13834 | PMID 30175463 Get It

Survival trends among non‐small‐cell lung cancer patients over a decade: impact of initial therapy at academic centers
Lou, Yanyan , Dholaria, Bhagirathbhai , Soyano, Aixa , Hodge, David O. , Cochuyt, Jordan J., Thomas, Mathew , Johnson, Margaret M. , Patel, Neal M. , Miller, Robert C. , Adjei, Alex A. , Hodge, David, Cochuyt, Jordan, Manochakian, Rami , Ko, Stephen J. , Ailawadhi, Sikander , Thomas, Mathew , Dholaria, Bhagirathbhai R , Soyano, Aixa , Ailawadhi, Sikander

Mayo Clinic

Cancer Medicine | September 2, 2018 | Volume: 7 | Issue: 10 | Pages: 4932-4942

10.1002/cam4.1749 | PMID 30175515 Get It

Abstract Background Treatment of non‐small‐cell lung cancer (NSCLC) has been rapidly advancing over the last decade. Academic centers are considered equipped with better expertise. NSCLC outcome trends in novel therapeutic era and impact of initial treatment at academic centers have not been reported. Methods The National Cancer Database (NCDB) was used to identify NSCLC incident cases from 2004 to 2013. Overall survival (OS) was plotted by year of diagnosis and type of initial treatment center, accounting for several factors available in NCDB. Results A total of 1 150 722 NSCLC patients were included and separated by initial treatment center type (academic: 31.5%; nonacademic: 68.5%). Median follow‐up and OS for all patients were 11.8 months (range: 0‐133.6 months) and 13.1 months (95% CI: 13.08‐13.17), respectively. Median OS improved significantly for those diagnosed in 2010‐2013 (14.8 months [95% CI: 14.7‐14.9]) as compared to 2004‐2009 (12.4 months [95% CI: 12.3‐12.5]) ( P < 0.001). Treatment at academic centers was associated with improved OS (multivariate HR for OS = 0.929 [95% CI: 0.92‐0.94], P < 0.0010). Four‐year OS for academic and nonacademic cohorts was 28.5%% and 22.1%, respectively ( P < 0.001), and the difference was more pronounced in stage I to III NSCLC. Conclusion In this largest analysis, thus far, NSCLC survival has improved over time, and type of initial treatment center significantly influences survival. Identifying and removing barriers to obtaining initial treatment of NSCLC at academic medical centers could improve OS.
Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations
Kornstein, Susan G., Joffe, Hadine , Freeman, Ellen W. , Athappilly, Geena, Rubin, Leah H. , Koleva, Hristina , Cohen, Lee S. , Bobo, William V. , Maki, Pauline M. , Bromberger, Joyce T. , Soares, Cláudio N.

Mayo Clinic

Menopause | September 2, 2018 | Volume: 25 | Issue: 10 | Pages: 1069-1085

10.1097/gme.0000000000001174 | PMID 30179986 Get It

Abstract There is a new appreciation of the perimenopause – defined as the early and late menopause transition stages as well as the early postmenopause - as a window of vulnerability for the development of both depressive symptoms and major depressive episodes. However, clinical recommendations on how to identify, characterize and treat clinical depression are lacking. To address this gap, an expert panel was convened to systematically review the published literature and develop guidelines on the evaluation and management of perimenopausal depression. The areas addressed included: 1) epidemiology; 2) clinical presentation; 3) therapeutic effects of antidepressants; 4) effects of hormone therapy; and 5) efficacy of other therapies (eg, psychotherapy, exercise, and natural health products). Overall, evidence generally suggests that most midlife women who experience a major depressive episode during the perimenopause have experienced a prior episode of depression. Midlife depression presents with classic depressive symptoms commonly in combination with menopause symptoms (ie, vasomotor symptoms, sleep disturbance), and psychosocial challenges. Menopause symptoms complicate, co-occur, and overlap with the presentation of depression. Diagnosis involves identification of menopausal stage, assessment of co-occurring psychiatric and menopause symptoms, appreciation of the psychosocial factors common in midlife, differential diagnoses, and the use of validated screening instruments. Proven therapeutic options for depression (ie, antidepressants, psychotherapy) are the front-line treatments for perimenopausal depression. Although estrogen therapy is not approved to treat perimenopausal depression, there is evidence that it has antidepressant effects in perimenopausal women, particularly those with concomitant vasomotor symptoms. Data on estrogen plus progestin are sparse and inconclusive.
Ixazomib: a novel drug for multiple myeloma
Zanwar, Saurabh , Abeykoon, Jithma P. , Kapoor, Prashant , Abeykoon, Jithma Prasad

Mayo Clinic

Expert Review of Hematology | September 1, 2018 | Volume: 11 | Issue: 10 | Pages: 761-771

10.1080/17474086.2018.1518129 | PMID 30173621 Get It